Elanco Animal Health Incorporated (ELAN)
After hours:
| Previous close | 13.57 |
| Open | 13.48 |
| Bid | 0.00 x 2200 |
| Ask | 0.00 x 1100 |
| Day's range | 12.69 - 13.49 |
| 52-week range | 7.88 - 16.88 |
| Volume | |
| Avg. volume | 4,109,016 |
| Market cap | 6.384B |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.50 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 17.75 |
PR NewswireElanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
- Reuters
UPDATE 1-Elanco appoints two directors after settling with activist Ancora
Elanco Animal Health said on Monday that it had appointed two new directors to its board after reaching an agreement with activist investor Ancora Holdings but stopped short of naming a new CEO. The company that makes medicines and vaccinations for pets and livestock said it has added Kathy Turner and Craig Wallace to the board of directors. that it wanted four board seats at Elanco and to replace CEO Jeffrey Simmons over "poor performance."
- PR Newswire
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors (the "Board"), effective immediately, expanding the Board to 14 members.
